Abstract
Dyskeratosis congenital (DC) is the first genetic syndrome described among telomeropathies. Its classical phenotype is characterized by the mucocutaneous triad of reticulated pigmentation of skin lace, nail dystrophy and oral leukoplakia. The clinical presentation, however, is heterogeneous and serious clinical complications include bone marrow failure, hematological and solid tumors. It may also involve immunodeficiencies, dental, pulmonary and liver disorders, and other minor complication. Dyskeratosis congenita shows marked genetic heterogeneity, as at least 14 genes are responsible for the shortening of telomeres characteristic of this disease. This review discusses clinical characteristics, molecular genetics, disease evolution, available therapeutic options and differential diagnosis of dyskeratosis congenita to provide an interdisciplinary and personalized medical assessment that includes family genetic counseling.
| Original language | English |
|---|---|
| Article number | 496 |
| Pages (from-to) | 1-11 |
| Number of pages | 11 |
| Journal | Genes |
| Volume | 13 |
| Issue number | 3 |
| Early online date | 11 Mar 2022 |
| DOIs | |
| Publication status | Published (in print/issue) - 11 Mar 2022 |
Bibliographical note
Publisher Copyright:© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Clinic
- Treatment
- Etiology
- Dyskeratosis congenita
- Telomeropathies
Fingerprint
Dive into the research topics of 'Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver